Close sidebar

Wayne Odesnik Retires After Receiving 15-Year Ban

Wayne Odesnik has been given a 15-year ban after a second doping violation. As a result, Odesnik has announced his retirement from tennis.


The 29-year-old tested positive for several banned substances, including steroids, during tests in December and January.

A statement from Odesnik reads,

“I am announcing my retirement from professional tennis on the ATP Tour effective immediately. […] In December 2014, I unknowingly ingested a contaminated over-the-counter supplement.

“Upon learning of my positive test results I was immediately heartbroken as words could not describe my shock and disappointment.

“Being the most tested American tennis player on the tour, I would never knowingly have taken any chance of consuming a banned substance.

“The contaminated product is currently with an independent accredited testing laboratory in California for further testing at my own expense, and I am currently considering my legal options.”

The ban has been backdated to January 30th and will end at midnight on January 29th 2030.

Odesnik provided an out-of-competition urine sample on December 14th 2014 and further samples on December 17th 2014 and January 12th 2015. The samples were sent to accredited laboratories in the United States and Canada for analysis.

His first violation came in 2010 when he was found guilty of possessing human growth hormone (HGH). He denied using the drug and repeatedly said that he never tested positive. The International Tennis Federation (ITF) banned him for two years but this was cut to one year due to his cooperation with the ITF.

The American was ranked as high as No.77 in the world but is currently at No.267.

Odesnik’s 2015 results will be disqualified. Any ranking points and prize money he accumulated will also be forfeited.

Eilís Brennan, Pundit Arena

Read More About: , , , , ,

Author: The PA Team

This article was written by a member of The PA Team. If you would like to join the team, drop us an email at write@punditarena.com.